Authors: Joseph T. DiPiro, Gary C. Yee, Robert Talbert
ISBN-13: 9780071478991, ISBN-10: 007147899X
Format: Hardcover
Publisher: McGraw-Hill Companies, The
Date Published: June 2008
Edition: 7th Edition
Dipiro, Joseph T., PharmD(Univ of Georgia)
Talbert, Robert L., PharmD(Univ of Texas) Yee, Gary C., PharmD(Univ of Nebraska)
Matzke, Gary R., PharmD(Univ of Pittsburgh)
Wells, Barbara G., PharmD(Idaho State Univ)
Posey, L. Michael, RPh(Pharmacy Editorial & News Services)
The seventh edition of the benchmark evidence-based pharmacotherapy text--now in full color!
Reviewer:Kristen M. Quinn, PharmD(Jeanes Hospital)
Description:This well rounded pharmacy reference updates the field in a detailed manner.
Purpose:The authors strive to advance the quality of patient care through evidence-based therapies and enhance the health of patients through disease-prevention strategies. The authors also try to instill motivation in young practitioners and challenge them to learn and apply new concepts.
Audience:Written by physicians and pharmacists, the book targets pharmacists and student pharmacists, as well as other healthcare professionals.
Features:It details principles of pharmacotherapy and treatment algorithms, using figures and tables to enhance learning and make the book easy to use.
Assessment:This book is, by far, one of the best in pharmacy. It is an exceptionally useful reference for both pharmacists and pharmacy students. It communicates a wealth of information that is well researched and referenced. The seventh edition is a much needed update.
Foreword | ||
Preface | ||
Contributors | ||
Guiding Principles of Pharmacotherapy | ||
Sect. 1 | Basic Concepts | |
1 | Pharmacoeconomics: Principles | |
2 | Health Outcomes and Quality of Life | |
3 | Clinical Pharmacokinetics and Pharmacodynamics | |
4 | Pediatrics | |
5 | Geriatrics | |
6 | Pharmacoepidemiology | |
7 | Clinical Toxicology | |
Sect. 2 | Cardiovascular Disorders | |
8 | Cardiovascular Testing | |
9 | Cardiopulmonary Resuscitation | |
10 | Hypertension | |
11 | Heart Failure | |
12 | Ischemic Heart Disease | |
13 | Myocardial Infarction | |
14 | Arrhythmias | |
15 | Cardiomyopathies | |
16 | Cardiac Transplantation | |
17 | Thromboembolic Disorders | |
18 | Stroke | |
19 | Hyperlipidemia | |
20 | Peripheral Vascular Disease | |
21 | Use of Vasopressors and Inotropes in the Pharmacotherapy of Shock | |
22 | Hypovolemic Shock | |
Sect. 3 | Respiratory Disorders | |
23 | Pulmonary Function Testing | |
24 | Asthma | |
25 | Chronic Obstructive Lung Disease | |
26 | Respiratory Distress Syndrome | |
27 | Drug-Induced Pulmonary Diseases | |
28 | Cystic Fibrosis | |
Sect. 4 | Gastrointestinal Disorders | |
29 | Evaluation of the Gastrointestinal Tract | |
30 | Gastroesophageal Reflux Disease | |
31 | Peptic Ulcer Disease | |
32 | Inflammatory Bowel Disease | |
33 | Nausea and Vomiting | |
34 | Diarrhea and Constipation | |
35 | Portal Hypertension and Cirrhosis | |
36 | Drug-Induced Liver Disease | |
37 | Pancreatitis | |
38 | Viral Hepatitis | |
39 | Liver Transplantation | |
Sect. 5 | Renal Disorders | |
40 | Assessment of Renal Function | |
41 | Acute Renal Failure | |
42 | Chronic Renal Insufficiency and End-Stage Renal Disease | |
43 | Renal Transplantation | |
44 | Hemodialysis and Peritoneal Dialysis | |
45 | Drug-Induced Renal Disease | |
46 | Glomerulonephritis | |
47 | Drug Therapy Individualization for Patients with Renal Insufficiency | |
48 | Electrolyte Homeostasis | |
49 | Acid-Base Disorders | |
Sect. 6 | Neurologic Disorders | |
50 | Evaluation of Neurologic Illness | |
51 | Multiple Sclerosis | |
52 | Epilepsy | |
53 | Status Epilepticus | |
54 | Acute Management of the Head Injury Patient | |
55 | Parkinson's Disease | |
56 | Pain Management | |
57 | Headache Disorders: Migraine and Cluster | |
Sect. 7 | Psychiatric Disorders | |
58 | Evaluation of Psychiatric Illness | |
59 | Childhood Disorders | |
60 | Eating Disorders | |
61 | Alzheimer's Disease | |
62 | Substance-Related Disorders: Overview and Depressants, Stimulants, and Hallucinogens | |
63 | Substance-Related Disorders: Alcohol, Nicotine, and Caffeine | |
64 | Schizophrenia | |
65 | Depressive Disorders | |
66 | Bipolar Disorder | |
67 | Anxiety Disorders | |
68 | Obsessive-Compulsive Disorder | |
69 | Sleep Disorders | |
Sect. 8 | Endocrinologic Disorders | |
70 | Diabetes Mellitus | |
71 | Thyroid Disorders | |
72 | Adrenal Gland Disorders | |
73 | Pituitary Gland Disorders | |
Sect. 9 | Gynecologic and Obstetric Disorders | |
74 | Pregnancy and Lactation: Therapeutic Considerations | |
75 | Infertility | |
76 | Contraception | |
77 | Menstrual-Related Disorders | |
78 | Hormone Replacement Therapy | |
Sect. 10 | Immunologic Disorders | |
79 | Function and Evaluation of the Immune System | |
80 | Systemic Lupus Erythematosus and Other Collagen Vascular Diseases | |
81 | Allergic and Pseudoallergic Drug Reactions | |
Sect. 11 | Bone and Joint Disorders | |
82 | Osteoporosis and Osteomalacia | |
83 | Rheumatoid Arthritis | |
84 | Osteoarthritis | |
85 | Gout and Hyperuricemia | |
Sect. 12 | Disorders of the Eyes, Ears, Nose and Throat | |
86 | Glaucoma | |
87 | Allergic Rhinitis | |
Sect. 13 | Dermatologic Disorders | |
88 | Acne and Psoriasis | |
89 | Drug-Induced Skin Reactions | |
Sect. 14 | Hematologic Disorders | |
90 | Hematopoiesis | |
91 | Anemias | |
92 | Coagulation Disorders | |
93 | Sickle Cell Anemia | |
94 | Drug-Induced Hematologic Disorders | |
Sect. 15 | Infectious Diseases | |
95 | Laboratory Tests to Direct Antimicrobial Pharmacotherapy | |
96 | Antimicrobial Regimen Selection | |
97 | Central Nervous System Infections | |
98 | Lower Respiratory Tract Infections | |
99 | Upper Respiratory Tract Infections | |
100 | Skin and Soft Tissue Infections | |
101 | Infective Endocarditis | |
102 | Tuberculosis | |
103 | Gastrointestinal Infections and Enterotoxigenic Poisonings | |
104 | Intra-abdominal Infections | |
105 | Parasitic Diseases | |
106 | Urinary Tract Infections and Prostatitis | |
107 | Sexually Transmitted Diseases | |
108 | Bone and Joint Infections | |
109 | Sepsis and Septic Shock | |
110 | Invasive Fungal Infections | |
111 | Infections in Immunocompromised Patients | |
112 | Antimicrobial Prophylaxis in Surgery | |
113 | Vaccines, Toxoids, and Other Immunobiologics | |
114 | Human Immunodeficiency Virus Infection | |
Sect. 16 | Oncologic Disorders | |
115 | Cancer Treatment and Chemotherapy | |
116 | Breast Cancer | |
117 | Lung Cancer | |
118 | Colorectal Cancer | |
119 | Prostate Cancer | |
120 | Malignant Lymphomas | |
121 | Ovarian Cancer | |
122 | Acute Leukemias | |
123 | Chronic Leukemias | |
124 | Melanoma | |
125 | Bone Marrow Transplantation | |
Sect. 17 | Nutrition and Nutritional Disorders | |
126 | Assessment of Nutrition Status and Nutrition Requirements | |
127 | Prevalence and Significance of Malnutrition | |
128 | Parenteral Nutrition | |
129 | Enteral Nutrition | |
130 | Pediatric and Geriatric Nutrition Support | |
131 | Nutritional Considerations in Major Organ Failure | |
132 | Obesity | |
Index |